190 related articles for article (PubMed ID: 20202087)
1. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.
Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Forteza J; Fraga M
J Oral Pathol Med; 2010 Aug; 39(7):571-8. PubMed ID: 20202087
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
3. [Mouth floor and mobile tongue epidermoid carcinomas thickness: prognostic value].
El-Okeily M; El-Bouihi M; Ricard AS; Lefebvre-Majoufre C; Deminière C; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2008 Apr; 109(2):81-5. PubMed ID: 18328517
[TBL] [Abstract][Full Text] [Related]
4. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
5. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and proliferation markers in tongue squamous cell carcinomas.
Gueiros LA; Coletta RD; Kowalski LP; Lopes MA
Int J Oral Maxillofac Surg; 2011 May; 40(5):510-5. PubMed ID: 21277167
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological factors in early squamous cell carcinoma of the tongue and floor of the mouth, in Biscay (the Basque Country, Spain).
Martínez-Conde R; Aguirre JM; Burgos JJ; Rivera JM
Med Oral; 2001; 6(2):87-94. PubMed ID: 11500624
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue.
Huang CF; Sun ZJ; Zhao YF; Chen XM; Jia J; Zhang WF
Oral Dis; 2011 Apr; 17(3):328-34. PubMed ID: 20796224
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of microinvasive stage I oral carcinoma.
Pentenero M; Navone R; Motta F; Marino R; Gassino L; Broccoletti R; Gandolfo S
Oral Dis; 2011 Apr; 17(3):298-303. PubMed ID: 20860767
[TBL] [Abstract][Full Text] [Related]
12. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.
Arduino PG; Carrozzo M; Chiecchio A; Broccoletti R; Tirone F; Borra E; Bertolusso G; Gandolfo S
J Oral Maxillofac Surg; 2008 Aug; 66(8):1570-9. PubMed ID: 18634942
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
[TBL] [Abstract][Full Text] [Related]
15. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
16. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth.
Pimenta Amaral TM; Da Silva Freire AR; Carvalho AL; Pinto CA; Kowalski LP
Oral Oncol; 2004 Sep; 40(8):780-6. PubMed ID: 15288831
[TBL] [Abstract][Full Text] [Related]
20. Catenin expression in T1/2 carcinomas of the floor of the mouth.
Fillies T; Buerger H; Gaertner C; August C; Brandt B; Joos U; Werkmeister R
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):907-11. PubMed ID: 15916880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
